Market Research Logo

Corcept Therapeutics Incorporated (CORT) - Financial and Strategic SWOT Analysis Review

Corcept Therapeutics Incorporated (CORT) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Corcept Therapeutics Incorporated (Corcept) is a research focused pharmaceutical company which discovers, develops and commercializes innovative therapeutics in the areas of psychiatric and metabolic diseases. The company focuses on developing drugs for the treatment of severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol. Corcept received approval from the US FDA for its lead product candidate Korlym (mifepristone), which modulates the effect of cortisol by selectively blocking the binding of the GR receptor. Korlym is the first drug candidate to be approved for the treatment of patients with Cushing’s syndrome. Other products in the pipeline include mifepristone for psychotic depression; CORT 108297 and other GR antagonists that help in the prevention of antipsychotic-induced weight gain mitigation. Corcept is headquartered in California, the US.

Corcept Therapeutics Incorporated Key Recent Developments

May 03, 2016: Corcept Therapeutics Announces First Quarter 2016 Financial Results and Provides Corporate Update
Mar 01, 2016: Corcept Therapeutics Announces 2015 Financial Results
Jan 28, 2016: Corcept Therapeutics Announces Preliminary Fourth Quarter and Full Year 2015 Summary Financial Results, Provides 2016 Revenue Guidance and Corporate Update
Nov 05, 2015: Corcept Therapeutics Announces Third Quarter 2015 Results and Provides Corporate Update
Sep 28, 2015: Corcept Therapeutics Appoints Robert S. Fishman, M.D., as Chief Medical Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Corcept Therapeutics Incorporated - Key Facts
Corcept Therapeutics Incorporated - Key Employees
Corcept Therapeutics Incorporated - Key Employee Biographies
Corcept Therapeutics Incorporated - Major Products and Services
Corcept Therapeutics Incorporated - Pharmaceutical Pipeline Products Data
Corcept Therapeutics Incorporated, Pipeline Products by Therapy Area
Corcept Therapeutics Incorporated, Pipeline Products by Development Phase
Corcept Therapeutics Incorporated - History
Corcept Therapeutics Incorporated - Company Statement
Corcept Therapeutics Incorporated - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Corcept Therapeutics Incorporated - Business Description
Corcept Therapeutics Incorporated - Corporate Strategy
Corcept Therapeutics Incorporated - SWOT Analysis
SWOT Analysis - Overview
Corcept Therapeutics Incorporated - Strengths
Strength - Sturdy R&D Activities
Strength - Korlym - Orphan Drug and Fast Track Designations
Corcept Therapeutics Incorporated - Weaknesses
Weakness - History of Losses
Corcept Therapeutics Incorporated - Opportunities
Opportunity - Emerging Markets
Opportunity - Market Potential-Psychotic Depression
Opportunity - Changing Demographics
Corcept Therapeutics Incorporated - Threats
Threat - Intense Competition
Threat - Uncertain R&D Outcomes
Threat - Reliance on Third Parties
Corcept Therapeutics Incorporated - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Corcept Therapeutics Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Corcept Therapeutics Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Corcept Therapeutics Incorporated, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 03, 2016: Corcept Therapeutics Announces First Quarter 2016 Financial Results and Provides Corporate Update
Mar 01, 2016: Corcept Therapeutics Announces 2015 Financial Results
Jan 28, 2016: Corcept Therapeutics Announces Preliminary Fourth Quarter and Full Year 2015 Summary Financial Results, Provides 2016 Revenue Guidance and Corporate Update
Nov 05, 2015: Corcept Therapeutics Announces Third Quarter 2015 Results and Provides Corporate Update
Sep 28, 2015: Corcept Therapeutics Appoints Robert S. Fishman, M.D., as Chief Medical Officer
Aug 05, 2015: Corcept Therapeutics Announces Second Quarter 2015 Results and Provides Corporate Update
Jun 22, 2015: Corcept Therapeutics Appoints Daniel Swisher to Board of Directors
May 07, 2015: Corcept Therapeutics Announces First Quarter 2015 Results and Provides Corporate Update
Mar 04, 2015: Corcept Therapeutics Announces 2014 Financial Results and Provides Clinical Update
Jan 29, 2015: Corcept Therapeutics Announces Fourth Quarter and Full Year 2014 Revenue, Provides 2015 Revenue Guidance and Clinical Update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Corcept Therapeutics Incorporated, Key Facts
Corcept Therapeutics Incorporated, Key Employees
Corcept Therapeutics Incorporated, Key Employee Biographies
Corcept Therapeutics Incorporated, Major Products and Services
Corcept Therapeutics Incorporated, Number of Pipeline Products by Therapy Area
Corcept Therapeutics Incorporated, Number of Pipeline Products by Development Stage
Corcept Therapeutics Incorporated, Pipeline Products By Therapy Area and Development Phase
Corcept Therapeutics Incorporated, History
Corcept Therapeutics Incorporated, Key Competitors
Corcept Therapeutics Incorporated, Ratios based on current share price
Corcept Therapeutics Incorporated, Annual Ratios
Corcept Therapeutics Incorporated, Interim Ratios
Corcept Therapeutics Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Corcept Therapeutics Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Corcept Therapeutics Incorporated, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Corcept Therapeutics Incorporated, Pipeline Products by Therapy Area
Corcept Therapeutics Incorporated, Pipeline Products by Development Phase
Corcept Therapeutics Incorporated, Performance Chart (2011 - 2015)
Corcept Therapeutics Incorporated, Ratio Charts
Corcept Therapeutics Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Corcept Therapeutics Incorporated, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report